Publication of Registration Document
The following Registration Document has been approved by the UK Listing Authority and is available for viewing:
Registration Document dated 30 July, 2008 in relation to GlaxoSmithKline plc; GlaxoSmithKline Capital plc and GlaxoSmithKline Capital Inc. - £10 billion Euro Medium Term Note Programme.
To view the full document, please paste the following URL into the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/2614A_1-2008-7-30.pdf
The documents incorporated by reference can be viewed at www.gsk.com/investors.
For further information, please contact:
GlaxoSmithKline
980 Great West Road
Brentford
Middlesex
TW8 9GS
Enquiries:
UK Media enquiries: |
Philip Thomson |
(020) 8047 5502 |
European Analyst/Investor enquiries: |
David Mawdsley |
(020) 8047 5564 |
|
Sally Ferguson |
(020) 8047 5543 |
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Registration Document may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Registration Document) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Registration Document is not addressed. Prior to relying on the information contained in the Registration Document you must ascertain from the Registration Document whether or not you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirement.